THDBH120
/ Tonghua Dongbao, WuXi AppTec
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
June 27, 2025
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
(clinicaltrials.gov)
- P2 | N=276 | Recruiting | Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
New P2 trial • Obesity
June 13, 2025
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM
(clinicaltrials.gov)
- P1 | N=49 | Completed | Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
April 30, 2025
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity
(clinicaltrials.gov)
- P1 | N=36 | Completed | Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
New P1 trial • Genetic Disorders • Obesity
December 20, 2024
A Single- and Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of THDBH120 Injection in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=72 | Completed | Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
New P1 trial
1 to 4
Of
4
Go to page
1